0.2355
price up icon0.21%   0.0005
after-market After Hours: .23 -0.0055 -2.34%
loading
Tonix Pharmaceuticals Holding Corp stock is traded at $0.2355, with a volume of 38.62M. It is up +0.21% in the last 24 hours and down -29.47% over the past month. Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
See More
Previous Close:
$0.235
Open:
$0.23
24h Volume:
38.62M
Relative Volume:
0.39
Market Cap:
$44.01M
Revenue:
-
Net Income/Loss:
$-121.02M
P/E Ratio:
-0.0209
EPS:
-11.26
Net Cash Flow:
$-114.09M
1W Performance:
-15.50%
1M Performance:
-29.47%
6M Performance:
-60.49%
1Y Performance:
-97.42%
1-Day Range:
Value
$0.2206
$0.2456
1-Week Range:
Value
$0.216
$0.2875
52-Week Range:
Value
$0.118
$12.48

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile

Name
Name
Tonix Pharmaceuticals Holding Corp
Name
Phone
212-980-9155
Name
Address
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
Employee
103
Name
Twitter
@TONIXPharma
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TNXP's Discussions on Twitter

Compare TNXP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
0.2355 44.01M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-18-22 Initiated Noble Capital Markets Outperform
Apr-18-19 Upgrade ROTH Capital Neutral → Buy
Aug-18-17 Upgrade ROTH Capital Neutral → Buy
Sep-07-16 Downgrade ROTH Capital Buy → Neutral
Feb-17-16 Reiterated Oppenheimer Outperform
Nov-04-15 Initiated Cantor Fitzgerald Buy
Jun-12-15 Initiated Oppenheimer Outperform
Feb-17-15 Reiterated ROTH Capital Buy
Sep-29-14 Reiterated ROTH Capital Buy
View All

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News

pulisher
Jan 18, 2025

Tonix Pharmaceuticals Holding (LTS:0A4T) Liabilities-to-Ass - GuruFocus.com

Jan 18, 2025
pulisher
Jan 17, 2025

Tonix Pharmaceuticals Holding (LTS:0A4T) Price-to-Operating-Cash-Flow : (As of Jan. 17, 2025) - GuruFocus.com

Jan 17, 2025
pulisher
Jan 17, 2025

FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Tonix Pharmaceuticals Holding (LTS:0A4T) Net Income : $-135.25 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 17, 2025
pulisher
Jan 17, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Hold Rating from Analysts at StockNews.com - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

Tonix Pharmaceuticals Holding (LTS:0A4T) Altman Z-Score : -14.06 (As of Jan. 16, 2025) - GuruFocus.com

Jan 16, 2025
pulisher
Jan 16, 2025

Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 16, 2025
pulisher
Jan 15, 2025

Tonix Pharmaceuticals Holding (LTS:0A4T) 9-Day RSI : N/A (As of Jan. 15, 2025) - GuruFocus.com

Jan 15, 2025
pulisher
Jan 10, 2025

Rivoluzionare la salute con i virus? Una nuova era per le scoperte biotecnologiche - Be3

Jan 10, 2025
pulisher
Jan 09, 2025

(TNXP)Analyzing Tonix Pharmaceuticals's Short Interest - Benzinga

Jan 09, 2025
pulisher
Jan 09, 2025

Revolutionizing Health with Viruses? A New Age for Biotech Breakthroughs - Be3

Jan 09, 2025
pulisher
Jan 08, 2025

Tonix Pharmaceuticals Further Strengthens Commercial - GlobeNewswire

Jan 08, 2025
pulisher
Jan 08, 2025

Tonix Pharma Announces Key Appointment and Study Timelines - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

Tonix Pharmaceuticals Strengthens Commercial Team Ahead of Critical FDA Decision on Fibromyalgia Drug - StockTitan

Jan 08, 2025
pulisher
Jan 08, 2025

Tonix Is A Buy For Potentially Great Return On PTSD Breakthrough, Part 2 (NASDAQ:TNXP) - Seeking Alpha

Jan 08, 2025
pulisher
Jan 07, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.2%Time to Sell? - MarketBeat

Jan 07, 2025
pulisher
Jan 07, 2025

Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase Transcript - GuruFocus.com

Jan 07, 2025
pulisher
Jan 07, 2025

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

Tonix Pharmaceuticals CEO to Present Pipeline Updates at Major Neuroscience and Biotech Forums - StockTitan

Jan 07, 2025
pulisher
Jan 06, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 2.5%Time to Buy? - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

SABBY MANAGEMENT, LLC Acquires 1,306,313 Shares in Tonix Pharmaceuticals Holding Corp - GuruFocus.com

Jan 06, 2025
pulisher
Jan 05, 2025

What’s Next for TNXP? The Future of Biotech and Stock Surges - Be3

Jan 05, 2025
pulisher
Jan 03, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.5%What's Next? - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

Tonix Receives PDUFA Goal Date for Sleep-Enhancing Fibromyalgia Drug Candidate - Sleep Review

Jan 03, 2025
pulisher
Jan 02, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.5%What's Next? - MarketBeat

Jan 02, 2025
pulisher
Jan 01, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 8.4%Time to Sell? - MarketBeat

Jan 01, 2025
pulisher
Jan 01, 2025

Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024 - MSN

Jan 01, 2025
pulisher
Jan 01, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by StockNews.com - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.8%Should You Sell? - MarketBeat

Dec 31, 2024
pulisher
Dec 30, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 5.3%What's Next? - MarketBeat

Dec 30, 2024
pulisher
Dec 27, 2024

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December - MarketBeat

Dec 27, 2024
pulisher
Dec 27, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.7%Time to Sell? - MarketBeat

Dec 27, 2024
pulisher
Dec 26, 2024

This Micro Cap Is Getting Bid Up Prior To Opening Bell - MSN

Dec 26, 2024
pulisher
Dec 26, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 2.6%Should You Sell? - MarketBeat

Dec 26, 2024
pulisher
Dec 25, 2024

Certain Options of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com

Dec 25, 2024
pulisher
Dec 25, 2024

Certain Common Stock of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com

Dec 25, 2024
pulisher
Dec 25, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.4%Time to Sell? - MarketBeat

Dec 25, 2024
pulisher
Dec 24, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2%What's Next? - MarketBeat

Dec 24, 2024
pulisher
Dec 24, 2024

FDA sets review goal date for Tonix fibromyalgia drug By Investing.com - Investing.com South Africa

Dec 24, 2024
pulisher
Dec 23, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 26.8%Should You Sell? - MarketBeat

Dec 23, 2024
pulisher
Dec 23, 2024

Tonix Pharma Awaits FDA Decision on TNX-102 SL - TipRanks

Dec 23, 2024
pulisher
Dec 23, 2024

FDA sets review goal date for Tonix fibromyalgia drug - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

Tonix Pharmaceuticals Announces PDUFA Goal Date of August - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

Tonix Pharmaceuticals' Groundbreaking Fibromyalgia Drug Gets FDA Fast Track & PDUFA Date - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - MarketBeat

Dec 23, 2024
pulisher
Dec 20, 2024

Tonix Pharmaceuticals ups offering to $250 million - Investing.com India

Dec 20, 2024

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
Cap:     |  Volume (24h):